Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae

Pediatrics

Volumn 102, Issue 6, 1998, Pages 1369-1375

  Tan, Tina Q ^a   Mason Jr , Edward O ^b   Barson, William J ^c   Wald, Ellen R ^d   Schutze, Gordon E ^e   Bradley, John S ^f   Arditi, Moshe ^g   Givner, Laurence B ^h   Yogev, Ram ^a   Kim, Kwang Sik ^g   Kaplan, Sheldon L ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Pediatrics; Penicillin resistance; Pneumococcal pneumonia

Indexed keywords

PENICILLIN G;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CHILD; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0031771516     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.102.6.1369     Document Type: Article

References (35)

1. Williams WW, Hickson MA, Kane MA, et al. Immunization policies and vaccine coverage among adults. Ann Intern Med. 1988;108:616-625
2. McCracken GH Jr. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J. 1995;14:424-428
3. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77-83
4. Coonrod JD. Pneumococcal pneumonia. Semin Respir Infect. 1989;4:4-11
5. Musher DM. Pneumococcal pneumonia including diagnosis and therapy of infections caused by penicillin-resistant strains. Infect Dis Clin North Am. 1991;5:509-521
6. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J. 1995;14:885-890
7. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Sixth informational supplement M1150-56. Wayne, PA: National Committee for Clinical Laboratory Standards; 1995
8. Minimum Inhibitory Concentration (MIC) Interpretive Standards (μg/ mL) for Streptococcus spp. Table 2C. M100-S7. NCCLS Vol 17. No 2. 1997
9. Marfin AA, Sporrer J, Moore PS, et al. Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest. 1995;107:457-462
10. Pallares R, Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987;317:18-22
11. Esposito AL. Community-acquired bacteremic pneumococcal pneumonia. Arch Intern Med. 1984;144:945-948
12. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 1995;333:474-480
13. Hardie WD, Roberts NE, Reising SF, et al. Complicated parapneumonic effusions in children caused by penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 1998;101:388-392
14. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med. 1980;69:507-512
15. Taryle DA, Potts DE, Sahn SA. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest. 1978;74: 170-173
16. Bryant RE, Salmon CJ. Pleural empyema. Clin Infect Dis. 1996;22:747-764
17. McLaughlin FJ, Goldmann DA, Rosenbaum DM, et al. Empyema in children: clinical course and long-term follow up. Pediatrics. 1984;73: 587-593
18. Murphy D, Lockhart CH, Todd JK. Pneumococcal empyema. Am J Dis Child. 1980;134:659-662
19. Hoff SJ, Neblett WW, Edwards KM, et al. Parapneumonic empyema in children: decortication hastens recovery in patients with severe pleural infections. Pediatr Infect Dis J. 1991;10:194-199
20. Gustafson RA, Murray GF, Warden HE, et al. Role of lung decortication in symptomatic empyemas in children. Ann Thorac Surg. 1990;49: 940-947
21. Kosloske AM, Cartwright KC. The controversial role of decortication in the management of pediatric empyema. J Thorac Cardiovasc Surg. 1988; 96:166-170
22. Foglia RP, Randolph J. Current indications for decortication in the treatment of empyema in children. J Pediatr Surg. 1987;22:28-33
23. Kern JA, Rodgers BM. Thoracoscopy in the management of empyema in children. J Pediatr Surg. 1993;28:1128-1132
24. Raffensperger JG, Luck SR, Shkolnik A, et al. Mini-thoracotomy and chest tube insertion for children with empyema. J Thorac Cardiovasc Surg. 1982;84:497-504
25. Ward J. Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects. Rev Infect Dis. 1981;3:254-265
26. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 1994;331: 377-382
27. Feldman C, Kallenbach JM, Miller SD, et al. Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med. 1985;313: 615-617
28. American Academy of Pediatrics, Committee on Infectious Diseases. Therapy for children with invasive pneumococcal infections. Pediatrics. 1997;99:289-299
29. Ginsburg CM, McCracken GH Jr, Nelson JD. Pharmacology of oral antibiotics used for treatment of otitis media and tonsillopharyngitis in infants and children. Ann Otol Rhinol Laryngol. 1981;84:37-43
30. Krause PJ, Owens NJ, Nightingale CH. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamathoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis. 1982;145:815-821
31. Tan TQ, Mason EO, Kaplan SL. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics. 1992;90:928-933
32. Kaplan SL. Serious pediatric infections. Am J Med. 1990;88:18S-24S
33. Steele RW, Bradsher RW. Ceftriaxone for the treatment of serious infections. Am J Dis Child. 1983;137:1044-1047
34. Trang JM, Jacobs RF, Kearns GL, et al. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob Agents Chemother. 1985;28:791-795
35. Scaglione F, Raichi M, Fraschini F. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate. J Antimicrob Chemother. 1990;26:1-10